United StatesStand No: 41M11
AbbVie Contract Manufacturing has a portfolio of state-of-the-art facilities, offering a broad range of capabilities in North America and Europe. For more than 30 years, AbbVie Contract Manufacturing has offered contract manufacturing services that spans biologics, potent, drug product, prefilled syringes, fermentation, as well as selling high quality active pharmaceutical ingredients (APIs).
ItalyStand No: 41L20
Abiogen Pharma S.p.A. Italy offers: licensing out opportunities from its own product portfolio, Clinical Supply, Contract Development and Manufacturing services. A state of the art facility, a strong knowledge and expertise acquired over many years of development and manufacturing of pharmaceuticals, guarantees Clients and Partners high quality standards services.
IndiaStand No: 41M52
Global CRO specialized in drug development and testing for chemical and biological molecules, partner to generic and innovator companies. Phase 1 BABE, PK studies, Phase II-III-IV clinical trials, services for Biologics and Biosimilars (Clinical comparability, PK/PD, immunogenicity, and selected characterisation services) and medical writing. Truly Independent - No stake or partnership with any pharmaceutical company 18 years consistent global track record Infrastructure, equipment and experienced team of 600+ for all challenges including FTF, 505(b)(2)s in the US Certifications: 27x successful US FDA, 20x WHO, 6x EMA, 13x ANVISA Brazil, 16X DCGI India
CanadaStand No: 41M30
Altasciences Clinical Research encompasses Algorithme Pharma in Montreal, QC, Vince & Associates Clinical Research in Overland Park, KS, as well as Algorithme Pharma USA in Fargo, ND, thereby making it one of the largest early phase clinical CROs in North America. With over 25 years of industry experience, Altasciences provides early phase clinical development services to an international customer base of biopharmaceutical and generic companies. Altasciences' full-service solutions offering in this critical stage of drug development includes medical writing, biostatistics, data management and bioanalysis.
Czech RepublicStand No: 41N34
APIGENEX s.r.o. is a contract research organization (CRO) based in Prague, Czech Republic, following successful research of former VÚFB (Research Institute for Pharmacy and Biochemistry) which terminated in 1992. We provide our clients, local and international pharmaceutical and chemical companies, with highly professionally performed services, which enable them to realize and accomplish their research plans in drug discovery and crop protection. APIGENEX offers collaboration in various research projects. We are able to synthesize potentially active compounds to a short deadline and to an excellent quality. The pharmacological department is able to conduct the basic pharmacological screening and assess the pharmacodynamic profile of efficient substances, with experimental studies performed in common laboratory small rodents. drug discovery peptide synthesis GMP production design and synthesis of drug-like compounds custom synthesis of synthons and chemical specialities combinatorial and solid phase chemistry experimental pharmacology and pharmacokinetic and pharmacodynamic studies (inflammatory, diabetes, cancer) clinical pharmacology, regulatory...
NetherlandsStand No: 41N14
Avivia is an independent specialized pharmaceutical development company engaged in drug repositioning, repurposing and reformulation. Our expertise and capabilities are centered around the development of value-added generic drugs, life cycle management of branded drug products, and complex formulation and CMC development of new drug products (NCE). We operate a hybrid business model combining CRO service activities with internal product development programs, whereby in both cases, we approach ‘development' as not just offering a technical solution but always part of a broader product-oriented strategy.
IndiaStand No: 41M12
Azidus CRO, based in Chennai, India. Conducts BA/BE studies (healthy volunteers and patients), clinical trials, clinical data management, pharmacovigilance and regulatory submission to the global drug regulatory agencies. 480 Bedded Clinical facility and bio-analytical facility with 26 LC-MS/MS and three ICPMS under one roof. Approved by ANVISA Brazil, inspected by USFDA, DCGI, MOH-Turkey, GLP-Poland, UAE, Chile Health Authority, submitted studies for Spain and Germany. Clinical Laboratory approved by CAP (College of American Pathologists) and NABL.
SwitzerlandStand No: 41N46
Baccinex is the preferential and highly recognized one-stop Swiss partner (CMO) for contract manufacturing of sterile lyophilized and liquid dosage forms. We routinely supply clinical medication for phase I, II and III trials to our (bio)pharmaceutical clients. We offer a complete service including: Liquid or lyophilized drug product manufacturing (under aseptic conditions, in vials or ampoules), secondary packaging (randomized labelling included), QC analytics (physicochemical and microbiological), stability studies (ICH conditions), pharmaceutical batch release, GMP storage, project management and development activities (which include: scale-up from laboratory scale, setting up of GMP process and lyophilization cycle development).
United KingdomStand No: 41M02
Contract Manufacturing Excellence with Cobra Biologics Cobra Biologics is a leading international contract development and manufacturing organisation (CDMO) providing a comprehensive biologics and pharmaceuticals service offering. Our multi-functional and experienced project teams nurture customers' products through to clinical and commercial manufacture within three GMP approved facilities. Expertise Cobra is a contract development and manufacturing organisation (CDMO) supporting the global life sciences industry in the development and manufacture of monoclonal antibodies (mAb), recombinant proteins, DNA, viruses, phage and cell line derived products and pharmaceuticals for clinical trials and commercial supply. For Gene Therapy products we can produce DNA, Adenovirus, AAV, Lentivirus and other virus material for both clinical and commercial supply. Cobra provides manufacturing technologies, platforms and solutions for gene therapy products. For our AAV and Lentivirus customers we have developed a High Quality DNA platform process to enable the rapid supply of small quantities of DNA material for the production...
GermanyStand No: 41N42
CW Research & Management GmbH, certified according to EN ISO 9001:2015, is an independent Contract Research Organization operating in the pharmaceutical, biotechnology, medical device and healthcare industry. Our expertise combined with many years of experience is the basis of our corporate philosophy and our success. Our team has been successfully managing numerous projects since 1993 in Germany, Austria and Switzerland from our offices based in Munich, Vienna and Adlwang (Upper Austria). Together with our contactors we manage your projects all across over Europe. Each project is different - unique in its structure, objectives and requirements. This requires the development of individually adapted solutions - individuality rather than uniformity. The diversity of our service portfolio allows us to develop tailor-made solutions for your company (all-inclusive concept as well as individual services). Our committed team of experts provides you with services on the following areas: Clinical Trials - Planning/Monitoring/Evaluation, Medical Writing, Data...
IndiaStand No: 41M51
Dorizoe Lifesciences Ltd is a purely Contract Research & Finished Product Development Organization based in India, working for Pharmaceutical Companies operating in Regulated Markets. We have strong capability in Finished Product Development of Parentral, Injectable (Lyophilized to Aqueous in Cytotoxic and Non Cytotoxic space) & Semi-Solids Like Creams, ointments & Gel in different delivery systems including Ampoules, Vials, PFS, PVC and Non - PVC bags and so on. At Dorizoe, we have very strong capability of developing injectables in cytotoxic to non cytotoxic space in lyophilized to aqueous form. After developing the product, we can also assist you for contract manufacturing by transferring the technology to your preferred CMO or at our recommended / preferred CMO partners. Apart from contract development, we also provide the Customized Services of Formulation and Development, Analytical Service, Quality Assurance, Regulatory Services and other Pharmaceutical Support Services. Currently we are working with the top pharmaceutical...
FranceStand No: 41L50
Eurofins Amatsigroup is a leading international Contract Development and Manufacturing Organization (CDMO), headquartered in France. Within Amatsigroup, we provide high-quality, customized and cost-effective drug development solutions, integrated under one roof, to small biotech and major (bio) pharmaceutical customers. Our innovative and flexible approach enables customers to speed up their drug development process, achieving key milestones in a timely manner. The company has three strategic pillars: Drug substance process development and manufacturing for biologics, Pharmaceutical analysis solutions: fit-for-purpose method developments and validations, stability studies and Quality Control (QC) Formulation development and manufacturing of sterile and non-sterile clinical or small commercial batches. Clients also benefit from complementary services such as in-life studies, bioanalysis and clinical trial supply (packaging & logistics). A broad scientific, technical and regulatory expertise, combined with proactive troubleshooting skills, are the key assets of the company. Our goal is to build a sustainable partnership with our customers to support...
FranceStand No: 41L30
Europhartech, a contract manufacturing and development organization, has been recognized by pharmaceutical (human and veterinarian) and food supplements industries, for the adaptability of its services and the mastery of its supply chain. Thanks to high performing equipment, with continuous developments, Europhartech manufactures, in a fullservice approach, solid dosage forms for oral use (princeps, hormones, hospital, unit dose, probiotics, generics and food supplements). Uncoated, film/sugar/coated, flash tablets, hard gelatin capsules, and plant extracts drying with microwave technology. Blisters packaging (PVC, multilayers/alu, alu/alu) pots filling with counting control. Europhartech also offers development services, including production of pilot batches, stabilities studies until the industrial transposition.
PolandStand No: 41N01
Institute of Industrial Organic Chemistry Branch Pszczyna is a pre-clinical contract research organization specializing in toxicological and ecotoxicological studies. As a GLP (Good Laboratory Practice) certified Institute we provide a wide range of services in the fields of human health protection and environmental safety, conduct studies of: plant protection products, pharmaceutical products, veterinary medical products, food and feed additives, industrial chemicals, biocides and industrial wastes. IPO offers research services in compliance with international guidelines: OECD, EU, EPPO, EMA, US EPA, SETAC/IOBC/BART/EPPO and ISO.
RomaniaStand No: 41L52
Magistra C&C is a Romanian producer of pharmaceutical products. Our production lines for the manufacturing of tablets, coated tablets, suppositories, ovules, creams, ointments and gels, are GMP certified in a new facility established in 2008, updated for the newest requisites in the Pharmaceutical Industry. Besides our main involvement in the Romanian pharmaceutical market, we also export our own products in the Russian Federation, Armenia, Azerbaijan, Georgia, Ukraine, Belarus, etc. and we perform contract manufacturing for important names in the pharmaceutical field. With a vast experience in the field, Magistra C&C is your perfect partner, complying with all current EU regulations.
GermanyStand No: 41N04
As a partner for the industry, Navitas Life Sciences leverages industry insights, consulting and technology capabilities to deliver full service clinical, regulatory and safety solutions and desired outcomes to our clients. Navitas Life Sciences, the dedicated life sciences company of TAKE Solutions, harnesses the combined knowledge and experience of three legacy companies—Ecron Acunova, Navitas, and Intelent—to provide end-to-end services and solutions. We help our clients address their most critical problems by bringing together the capabilities of a full-service CRO, a technology-led life sciences services provider across clinical, regulatory and safety, and a life sciences big data services and analytics provider. With a rich legacy of experience in life sciences, we have worked with 9 of the top 10 global pharma companies.
GermanyStand No: 41N30
Fully integrated Contract Research Organisation with over 35 years of serving the pharmaceutical industry. NUVISAN Pharma Services is a global provider of product development and support services to the pharmaceutical, biotechnology and medical device industries. We deliver services ranging from a single test to fully integrated drug development programs. We are pleased to offer our sponsors the complete spectrum of drug development services and assist the sponsor in bringing safe and effective pharmaceutical products to market. A leading CRO driven by Experience, Commitment, and Technology under one roof.
United KingdomStand No: 41N22
We are an international publishing and media organisation, dedicated to the pharmaceutical and bio-pharmaceutical industry. With comprehensive publications for the development of human health, veterinary medicine and feed, and clinical studies, we publish peer reviewed journals, bringing up to date information across these industries. Combining print and new electronic mediums, we are your ideal partner for your communication and marketing activities.
FranceStand No: 41N24
International leader in clinical evaluations for almost 30 years, Pharmascan is the pharmaceutical part of Dermscan Group conducting studies in international investigation centers, medical offices and/or hospitals. ISO 9001 certified, Pharmascan offers you quality standard or custom-made protocols to evaluate safety, tolerance and efficacy of health products.
Czech RepublicStand No: 41N40
Quinta-Analytica is a leading Central and East European contract research organization located in Prague, Czech Republic, whose primary task is to supply pharmaceutical companies with comprehensive analytical and clinical services. For both small molecules and biopharmaceuticals, Quinta-Analytica offers the following services: analytical methods development; validation and transfer for the evaluation of drug substances; intermediates and/or pharmaceutical products; also including chiral separation and impurity isolation and identification; quality control and release testing; stability studies; clinical trials; and pharmacokinetic/toxicokinetic studies in man and/or animals. Quinta-Analytica operates in full compliance with GCP/GLP/GMP and FDA standards.
IndiaStand No: 41N44
Raptim Research Ltd. is a quality-oriented full-service contract (clinical) research organization. Raptim provides end-to-end services to global Pharmaceutical (generic as well as research-based), Biotechnology and Cosmetic industry. The studies done at Raptim are globally submitted and approved by various regulatory agencies including USFDA, EMA, UK MHRA, Canada (TPD), WHO and etc. Raptim Research Ltd., incorporated in the year 2005, has its facilities based in Navi Mumbai and Business Office in Navi Mumbai as well as New Jersey, USA. Raptim is leader following activities: Bioequivalence / Bioavailability Studies (BE/BA studies) PK end-point studies PD end-point studies Clinical trials – phase II & IV Studies on Special Population Apart from the above, Raptim has developed expertise in niche area of drug development and has pioneered in testing/screening Dermal Topical Products including Cosmetic Products as well as inhalation products. These include: In vitro Release/Permeation (IVRT/IVPT) studies In vivo – Tape Stripping studies In...
IndiaStand No: 41M50
Rubicon Research Pvt. Ltd. is an emerging pharmaceutical company, focused on developing value added products for the pharmaceutical industry. Rubicon is a preferred partner for the industry in the development of specialized oral solid, oral liquid and topical dosage forms. Rubicon's proprietary technologies provide solutions for bioavailability enhancement, gastric retention, taste masking, and customizing the release profiles. We provide complete spectrum of services in the drug development program for our global partners consisting of formulation development, analytical development, stability evaluations, technology transfer and commercial manufacturing. The company's current supply chain includes manufacturing products for the US, EU, Turkey and Korean market. The Company operates out of two locations, the R&D center based in Mumbai, India and USFDA/MHRA approved manufacturing facility based out of Ambernath, India.
IndiaStand No: 41N20
Stabicon Life Sciences is a Research Organization offering Formulation Development,In-vitro, stability study management and Analytical Development Services. Some of the services provided by Stabicon currently include specialized and focused services for Complete Formulation Development, Stability Study Management including storage of samples, analysis and preparation of required documentation, associated analytical method development and validations for different phases of drug development program. Contracting Formulation Development, Stability Studies to us allows our customers to allocate their In-House resources for strategic projects. Stabicon's modern Research and Development facility is located in Bangalore, India.
IndiaStand No: 41N32
Synchron is India's first internationally recognized Contract Research Organization, which started its operations in 1998. Synchron undertakes Phase I to IV Clinical trials, Bio-equivalence studies, Therapeutic equivalence studies & Pk/Pd studies. We have a robust experience of conducting BE studies with the facility being audited by the regulatory agencies like MHRA, US-FDA, AFFSAPS, MoH Turkey & DCG(I). We are among the first few CROs, who initiated conduct of Phase II to IV Clinical trials in India, initially as a partner to globally recognized CRO PAREXEL, and then managing multi-centric Clinical trials on our own.
IndiaStand No: 41M40
TherDose was initially built with a vision of creating a technology and therapeutic area research based speciality pharmaceutical company. With core expertise in the area of dosage form design and development, we are uniquely positioned to rapidly develop value added therapeutics that make a difference in people's lives. We are currently operating a partnership based model where we develop and commercialize dosage forms with corporate partners located worldwide. We specialize in developing/using drug delivery/formulation technologies that provide the highest therapeutic differentiation. After clearly establishing ourselves as a reputed R&D company, now we're envisaging the opportunities in the area of manufacturing oncology injectables, which are categorized as speciality segments, for distributing them worldwide at the most affordable prices.
IndiaStand No: 41M32
VerGo is a rapidly growing Contract Research Organization(CRO) providing a diverse portfolio of services to pharmaceutical & clinical R&Ds worldwide like end to end Product development, Custom Synthesis, Stability studies, Clinical Batch Manufacturing, Clinical research impurities and metabolite synthesis and Regulatory support to domestic and global clients
BelgiumStand No: 41N12
Xedev is a contract development company in early stage feasibility Particle Engineering by Agglomeration / Coating / Drying. Fields of experitise are; Microencapsulation, Solid Dispersions, Controlled Release, Particle Agglomeration and Drying Development. Xedev's key to success is based on the combination of know-how in equipment engineering, process and product. The available technologies; spray dryer, fluid bed, high shear granulator, vacuum dryer, microwave dryer, nutsche filter, extruder spheroniser, homogeniser, tablet/capsule coater. Through partnerships are available; GMP infrastructure, Pre-clinical phase II, Analytical Dev, Stability and Bioequivalaent studies, Regulatory, Scale-up to pilot and production.